JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.71, sa.6, ss.1672-1680, 2016 (SCI-Expanded)
Objectives: Data about the efficacy of ertapenem for the treatment of bloodstream infections (BSI) due to ESBL-producing Enterobacteriaceae (ESBL-E) are Limited. We compared the clinical efficacy of ertapenem and other carbapenems in monomicrobial BSI due to ESBL-E.